USANA Health Sciences Inc (USNA)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 856,402 | 864,228 | 877,532 | 902,933 | 923,927 | 930,694 | 950,819 | 977,178 | 1,001,860 | 1,041,382 | 1,082,496 | 1,155,009 | 1,190,168 | 1,235,586 | 1,258,823 | 1,180,028 | 1,137,751 | 1,095,421 | 1,057,506 | 1,054,531 |
| Receivables | US$ in thousands | 8,223 | — | — | — | 7,201 | — | — | — | 7,213 | — | — | — | 7,163 | — | — | — | 7,420 | — | — | — |
| Receivables turnover | 104.15 | — | — | — | 128.31 | — | — | — | 138.90 | — | — | — | 166.15 | — | — | — | 153.34 | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $856,402K ÷ $8,223K
= 104.15
The receivables turnover ratio for USANA Health Sciences Inc has shown fluctuating trends over the reported periods.
For December 31, 2020, the receivables turnover ratio was 153.34, indicating that the company collected its accounts receivable approximately 153 times during that period. This high turnover ratio suggests that USANA Health Sciences Inc was efficient in converting its credit sales into cash, which is generally a positive sign of effective receivables management.
Subsequently, the ratio decreased to 166.15 by December 31, 2021, and further to 138.90 by December 31, 2022. The reduction in the receivables turnover ratio may imply that the company may have slowed down its collection efforts or experienced challenges in collecting outstanding receivables compared to the previous period.
By December 31, 2023, the ratio dropped to 128.31, and by December 31, 2024, it declined further to 104.15. These lower ratios indicate a potential extension in the collection period of accounts receivable, which could be a concern as it may tie up cash that could have been used for other purposes.
Overall, the declining trend in the receivables turnover ratio for USANA Health Sciences Inc highlights the importance of efficiently managing accounts receivable to maintain healthy cash flows and working capital levels. Further analysis and monitoring of the company's receivables management practices may be warranted to address any potential issues impacting the collection of outstanding balances.